CAT and colorectal carcinoma: In our study, all the OS markers of the CRC patients presented significant differences during the follow-up compared with the control group, especially at baseline and at 1 and 6 months; at 12 months, the differences were less significant for CAT, GSSG and GSSG/GSH.